Humidity helps your nose eliminate viruses

The nose and sinuses are designed to protect us from viruses using small, finger-like projections called cilia that literally beat back infections. Cilia love humidity; when your sinuses and nasal passages get too dry, the cilia have a hard time doing their job and microbes get stuck in there. This is why pediatricians love humidifiers…

Details

Younger adults are also impacted by COVID in the US

While older individuals and those with underlying health conditions are still most at risk from COVID-19, more than one-third of those who have contracted the virus are aged 44 years and below. This age group also accounts for 20 percent of all hospitalizations and 12 percent of ICU admissions. None of us can be complacent…

Details

COVID-19 *MAY* present with digestive symptoms

Digestive symptoms may be the first signs of COVID-19 infection, for some people. While a dry cough and fever are typically conveyed as the symptoms to watch out for, this new study in the American Journal of Gastroenterology reports that some individuals may also/predominantly experience loss of appetite, loose stool, vomiting, and abdominal discomfort, together…

Details

Why are we considering palmitoylethanolamide (PEA) for COVID19?

Why are we considering palmitoylethanolamide (PEA) for COVID19? We have been interested in this molecule for years and have used in our allergy patients (it has well-documented mast cell stabilizing properties), in our pain patients and as influenza treatment and prophylaxis. In this most recent COVID19 pandemic, I think PEA is worth considering, although we…

Details

COVID in Italy – One physician’s FxMed approach

Dr. Manuel Salvadori, Functional Medicine physician in Italy, is addressing those with COVID19 in his practice using the following protocol. To quote him directly in response to me asking how his patients were faring with what he’s prescribing: “It’s not possible to evaluate results on the CoVID-19, as you can’t really tell if people are…

Details

COVID-19 Pharma Treatment Shows Promise

Promising pharmaceutical treatment (a repurposed flu drug) for early-stage COVID-19 could be available as early as May. Testing in 340 patients in Japan appears to reduce the median duration of infection from 11 to 4 days. 91% of those treated showed improved lung condition compared to 62% without treatment. Early intervention may be key as…

Details

Peanut IgE+ B Cells Aren’t Just in Blood

The gut is a major site for IgE-producing B cells in peanut-allergic patients, defined for the first time by new research. The authors also found evidence suggesting that isotype switching can occur in GI tissue – including switching from IgA and IgG to IgE immunoglobulin types. This new understanding presents opportunities for future interventions to…

Details

Have You Heard of Experience Extinction?

Can we describe experiences as becoming extinct? How many of us are lacking the following: time spent in nature, and contact with biodiverse environments and microbes? Children especially, occupied by homework and screens, can miss out. Jeff Bland and Susan Prescott coauthored this new peer-reviewed paper that paints an expansive and remarkable view of the…

Details